Commonwealth Pharmacists Association, London, England.
Department of Pharmacy, University of Zambia, Lusaka, Zambia.
Bull World Health Organ. 2023 Jun 1;101(6):403-411. doi: 10.2471/BLT.22.288650. Epub 2023 Apr 17.
Efficient and secure supply chains are vital for effective health services worldwide. In low- and middle-income countries, the accessibility, affordability and availability of essential medicines, including antimicrobials, remain challenging. Ineffective supply chains often cause antimicrobial shortages, leading to inappropriate use of alternative agents and increasing the risk of antimicrobial resistance. Shortages, coupled with insecure supply chains, also encourage the infiltration of substandard and falsified medicines, leading to suboptimal treatment and further promoting antimicrobial resistance. Addressing antimicrobial supply-chain issues should be considered a key component of antimicrobial stewardship programmes. We have explored the link between medicine supply chains and antimicrobial use in seven focus countries: Kenya, Malawi, Nigeria, Sierra Leone, Uganda, United Republic of Tanzania and Zambia. We explored country medicine supply-system structures, national medicine supply-chain policy documents and global study reports. Our aim was to develop evidence-based strategies to enhance the effectiveness and efficiency of the medicine supply chains in supporting antimicrobial stewardship efforts. Better management of medical supply chains involves rational selection, quantification, forecasting, procurement, storage, distribution, use and stock management of antimicrobials. Important supply-chain considerations include pooled procurement networks to ensure consistent pricing of quality-assured antimicrobials, and improved resource utilization and information exchange among relevant stakeholders. We propose adaptable recommendations for integrating medicine supply chains as an essential part of antimicrobial stewardship programmes, with a call for action at the local, regional and national levels in low- and middle-income countries.
高效且安全的供应链对于全球有效的卫生服务至关重要。在低收入和中等收入国家,包括抗菌药物在内的基本药物的可及性、可负担性和可获得性仍然具有挑战性。低效的供应链常常导致抗菌药物短缺,导致不合理地使用替代药物,并增加抗菌药物耐药性的风险。短缺加上供应链不安全,也会鼓励劣质和假冒药品的渗透,导致治疗效果不佳,并进一步促进抗菌药物耐药性的产生。解决抗菌药物供应链问题应被视为抗菌药物管理计划的关键组成部分。我们在七个重点国家(肯尼亚、马拉维、尼日利亚、塞拉利昂、乌干达、坦桑尼亚联合共和国和赞比亚)探索了药品供应链与抗菌药物使用之间的联系。我们研究了各国药品供应系统结构、国家药品供应链政策文件和全球研究报告。我们的目的是制定基于证据的策略,以提高药品供应链在支持抗菌药物管理工作方面的有效性和效率。更好地管理医疗供应链涉及抗菌药物的合理选择、量化、预测、采购、储存、配送、使用和库存管理。供应链的重要考虑因素包括汇集采购网络,以确保质量保证的抗菌药物的价格一致,并提高相关利益攸关方之间的资源利用和信息交流。我们提出了适应性建议,将药品供应链整合为抗菌药物管理计划的重要组成部分,并呼吁在低收入和中等收入国家的地方、区域和国家各级采取行动。